Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation

Jin Wook Lee, Byung‐Chul Oh|Experimental & Molecular Medicine|2023

Cited by 26